Tuesday, October 2, 2018

Sanofi SA said on Friday its skin cancer drug, made in partnership with Regeneron Pharmaceuticals Inc, was approved by the U.S. Food and Drug Administration.


from Reuters: Health News https://ift.tt/2R8iKNC

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - - Millions of Americans have searched Google for information on how to understand, prevent and report sexual harassment and assault since the start of the #MeToo movement more than a year ago, a U.S. study … Read More
  • LATEST HEALTH NEWSMerck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients. from Reuters: Health News https://reut.rs/2rOL108 … Read More
  • LATEST HEALTH NEWS(Reuters Health) - - Isotretinoin, a drug for severe chronic acne, has long been linked to miscarriages, birth defects and other serious problems, but a research review suggests much of data on the drug's safety, effectivenes… Read More
  • LATEST HEALTH NEWSThe U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease in adults and children aged two years and above. from Reuters: Health News https://r… Read More
  • LATEST HEALTH NEWS(Reuters Health) - - For years, researchers have been studying medical conditions using huge swaths of patient data with identifying information removed to protect people's privacy. But a new study suggests hackers may be abl… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner